EUVIMEDEUVIMED entdecken
Crossref

Appropriate Statin Use in Patients With Newly Diagnosed Acute Ischemic Stroke or Myocardial Infarction at a Tertiary County Teaching Hospital

Soomin Woo, Charles F Seifert iD

Annals of Pharmacotherapy · 2025

DOI: 10.1177/10600280241305436 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Soomin Woo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock, TX, USA. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Myocardial Infarction, Ischemic Stroke. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Statins are the mainstay of therapy in patients suffering an acute ischemic stroke (AIS) or myocardial infarction (MI); however, several studies have shown that prescribing is not optimal.

Objective

The main objective of this study was to evaluate the percentage of patients prescribed appropriate statin therapy upon discharge after an AIS or MI.

Methods

This is a single-center retrospective cohort study conducted at a tertiary, county, teaching hospital in patients aged 18 to 89 years who were newly diagnosed with AIS or MI, from September 2017 to September 2022.

Results

Six hundred thirty-six individuals were hospitalized for AIS or MI according to ICD-10 codes. Of these, 389 patients were excluded, and 247 were included in the analysis. Although 85% of AIS and MI patients were at very high risk of future ASCVD events, over 25% were not discharged on appropriate statin therapy. Patients who had been taking high-intensity statins or were statin-naïve prior to admission (156/194, 80.4%) were significantly more likely to be discharged with appropriate statin therapy compared to those who had been taking low or moderate-intensity statins at home (27/53, 50.9%, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsMyocardial InfarctionIschemic StrokeHumansRetrospective StudiesMaleMiddle AgedAgedFemaleHospitals, TeachingAged, 80 and overAdultTertiary Care CentersYoung AdultAdolescentHospitals, CountyPatient DischargeCohort Studies

Stichwörter der Autor:innen

HMG Coenzyme A reductase inhibitorsacute ischemic strokeacute myocardial infarctionprescribing practicesstatins

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacy Practice, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

ORCID-Profile: Charles F Seifert

Zitieren

APA

Woo, S., & Seifert, C. F. (2025). Appropriate Statin Use in Patients With Newly Diagnosed Acute Ischemic Stroke or Myocardial Infarction at a Tertiary County Teaching Hospital. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280241305436

Vancouver

Woo S, Seifert CF. Appropriate Statin Use in Patients With Newly Diagnosed Acute Ischemic Stroke or Myocardial Infarction at a Tertiary County Teaching Hospital. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280241305436

BibTeX
@article{Woo2025,
  author = {Woo, Soomin and Seifert, Charles F},
  title = {Appropriate Statin Use in Patients With Newly Diagnosed Acute Ischemic Stroke or Myocardial Infarction at a Tertiary County Teaching Hospital},
  journal = {Annals of Pharmacotherapy},
  year = {2025},
  doi = {10.1177/10600280241305436}
}
Kostenlos starten →